[ad_1]
(KPLC / Gray News) – According to the FDA, two other drugs for hypertension have been recalled because of the possible presence of process impurities or contaminants in an active pharmaceutical ingredient.
Legacy Pharmaceutical Packaging LLC. recalls 40 batches of Losartan potassium tablets, USP, 25 mg, 50 mg and 100 mg, as well as three reconditioned batches of Losartan potassium tablets, USP, 50 mg due to the detection of traces of N-Nitroso N- Methyl 4- amino butyric acid (NMBA), says the FDA. NMBA is a potential carcinogen for humans.
Both drugs are used to treat high blood pressure and congestive heart failure, says the FDA. The company has had no reports of adverse effects related to this recall.
The FDA told patients to return all recalled products to the pharmacy. These products have been distributed throughout the country.
To see the list of products covered by this new reminder, click here.
These recalls add to the other five drug-related recalls for the treatment of hypertension. Here is the complete list:
1. Losartan Potassium Tablets USP and Losartan Potassium / Hydrochlorothiazide Tablets USP
2. tablets of valsartan and amlodipine and valsartan
3. Losartan Tablets USP 25 mg, 50 mg and 100 mg
4. Combination tablets of potassium and hydrochlorothiazide of losartan
5. Tablets of valsartan USP
See the current recalls here and here.
Copyright 2019 KPLC via Gray Television Group, Inc. All Rights Reserved.
[ad_2]
Source link